Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Langdon

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
The British Journal of Cancer. Supplement|June 1, 1991
Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrateF G Hay, L W Duncan, S P Langdon, et al.
Journal of Chromatography. B, Biomedical Applications|March 4, 1994
Determination of two neuropeptide growth factor antagonists, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P and [Arg6,D-Trp7,9,N-MePhe8]- substance P(6-11), by high-performance liquid chromatography with electrochemical detectionJ Cummings, A MacLellan, S P Langdon, et al.
Differentiation; Research in Biological Diversity|August 1, 1992
The influence of type I collagen on the growth and differentiation of the human colonic adenocarcinoma cell line HT-29 in vitroJ A East, S P Langdon, K M Townsend, et al.
British Journal of Cancer|October 1, 1996
Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumoursK E Wilson, S P Langdon, A M Lessells, et al.
Biochemical Pharmacology|March 1, 1982
Studies of the mode of action of antitumour triazenes and triazines-III. Metabolism studies on hexamethylmelamineC Brindley, A Gescher, S P Langdon, et al.
Toxicology|February 1, 1985
Studies on the toxicity of the antitumour agent N-methylformamide in miceS P Langdon, D Chubb, A Gescher, et al.
Biochemical Pharmacology|August 25, 1995
Characterization of the deamidase enzyme responsible for the metabolism of the anticancer peptide: H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2D A Jones, J Cummings, S P Langdon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2009
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastasesS J Aitken, J S Thomas, S P Langdon, et al.
British Journal of Cancer|March 5, 2002
Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa")J M Sewell, K G Macleod, A Ritchie, et al.
British Journal of Cancer|May 5, 2005
Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomasO Gubbay, W Guo, M T Rae, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
The British Journal of Cancer. Supplement|June 1, 1991
Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrateF G Hay, L W Duncan, S P Langdon, et al.
Journal of Chromatography. B, Biomedical Applications|March 4, 1994
Determination of two neuropeptide growth factor antagonists, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P and [Arg6,D-Trp7,9,N-MePhe8]- substance P(6-11), by high-performance liquid chromatography with electrochemical detectionJ Cummings, A MacLellan, S P Langdon, et al.
Differentiation; Research in Biological Diversity|August 1, 1992
The influence of type I collagen on the growth and differentiation of the human colonic adenocarcinoma cell line HT-29 in vitroJ A East, S P Langdon, K M Townsend, et al.
British Journal of Cancer|October 1, 1996
Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumoursK E Wilson, S P Langdon, A M Lessells, et al.
Biochemical Pharmacology|March 1, 1982
Studies of the mode of action of antitumour triazenes and triazines-III. Metabolism studies on hexamethylmelamineC Brindley, A Gescher, S P Langdon, et al.
Toxicology|February 1, 1985
Studies on the toxicity of the antitumour agent N-methylformamide in miceS P Langdon, D Chubb, A Gescher, et al.
Biochemical Pharmacology|August 25, 1995
Characterization of the deamidase enzyme responsible for the metabolism of the anticancer peptide: H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2D A Jones, J Cummings, S P Langdon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2009
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastasesS J Aitken, J S Thomas, S P Langdon, et al.
British Journal of Cancer|March 5, 2002
Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa")J M Sewell, K G Macleod, A Ritchie, et al.
British Journal of Cancer|May 5, 2005
Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomasO Gubbay, W Guo, M T Rae, et al.
Pageof 8